1-Ethyl-1H-pyrazol-5-amine → HCID 9902007, Verbindung
Reaktionsgleichung
[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([C:15]([OH:17])=O)=[C:7]2[C:11]=1[O:10][C:9]([CH2:12][O:13][CH3:14])=[CH:8]2.[CH2:18]([N:20]1[C:24]([NH2:25])=[CH:23][CH:22]=[N:21]1)[CH3:19]>>[CH2:18]([N:20]1[C:24]([NH:25][C:15]([C:6]2[CH:5]=[CH:4][C:3]([O:2][CH3:1])=[C:11]3[O:10][C:9]([CH2:12][O:13][CH3:14])=[CH:8][C:7]=23)=[O:17])=[CH:23][CH:22]=[N:21]1)[CH3:19]Komponenten
3
Versuchsvorschrift
Starting from 7-methoxy-2-methoxymethylbenzofuran-4-carboxylic acid (0.15 g) and 2-ethyl-2H-pyrazol-3-ylamine (85 mg). Purification by column chromatography on silica eluting with 50% ethyl acetate in heptane increasing to ethyl acetate afforded the title compound as a yellow solid (35 mg).
Aufarbeitung
- customPurification by column chromatography on silica eluting with 50% ethyl acetate in heptane increasing to ethyl acetate
Quellen und Nachweise
- ORD-Eintrag
- ord-5cbffa593c47429d90f7ca0421172eb0
- Quelldatensatz
- uspto-grants-2002_09
- Patentnummer
- US06455561B1
Notizen zur Reaktion
Wird geladen…